Latest Technology News

Lindian Resources has appointed DRA Pacific to lead the Kangankunde Stage 2 Expansion Study, aiming to scale rare earths production amid strong market demand. This move follows the recent Final Investment Decision for Stage 1, targeting first production in 2026.

Micro-X Ltd has secured a $4.4 million Australian Government grant to develop and trial a portable Head CT scanner designed for standard ambulances, aiming to transform emergency stroke care with faster diagnosis and treatment.

Metal Bank Limited moves swiftly to expand its Western Australian gold footprint through the acquisition of Hastings Technology Metals’ gold assets and a $2.3 million capital raising aimed at fast-tracking exploration and production.

Metal Bank Limited (ASX – MBK) has announced a partially underwritten entitlement offer aiming to raise $2.32 million to fast-track its Western Australia gold projects and explore graphite potential in Queensland. The offer, priced at $0.014 per share, is supported by Equator Capital Management Ltd and targets existing shareholders.

Range International has raised A$1.57 million through a discounted share placement to fund growth initiatives in Indonesia and the Philippines, alongside a key board appointment.

Terra Critical Minerals has revealed new high-grade silver mineralisation at its Mole River project in NSW, with samples reaching 400 g/t silver. This discovery at the Silent Grove prospect adds momentum to the company’s polymetallic exploration ambitions.

Way2VAT is advancing its position as a global leader in digital tax processing through a strategic acquisition and a robust four-pillar growth plan, targeting profitability by 2026 amid expanding market opportunities.

Way2VAT Ltd has secured a strategic acquisition of UK-based RBC VAT Limited alongside a $4.1 million placement, accelerating its expansion in VAT compliance and consultancy services.

Telix Pharmaceuticals secures Transitional Pass-Through payment status for its next-generation prostate cancer imaging agent Gozellix, paving the way for broader US patient access and streamlined provider reimbursement.

Bio-Gene Technology’s novel acaricide Flavocide demonstrated over 90% mortality against Lyme disease-carrying ticks in lab tests presented by Purdue University, highlighting its potential in public health applications.

Klevo Rewards Limited has initiated a non-renounceable entitlement offer to raise up to $4.1 million by issuing new shares at $0.009 each, inviting existing shareholders to participate by 1 October 2025.

Arovella Therapeutics has received a $3.21 million R&D tax incentive refund, bolstering its financial position as it prepares to initiate first-in-human trials for its lead cell therapy, ALA-101.